Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sabal Trust CO decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,903 shares of the biopharmaceutical company’s stock after selling 277 shares during the period. Sabal Trust CO’s […]
Pacific Sage Partners LLC cut its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 15.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,230 shares of the biopharmaceutical company’s stock after selling 575 shares during the quarter. Pacific Sage […]
Bailard Inc. trimmed its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 22.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 177,375 shares of the biopharmaceutical company’s stock after selling 51,367 shares during the period. Bailard Inc.’s holdings in […]
Revolve Wealth Partners LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 24.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,785 shares of the biopharmaceutical company’s stock after purchasing an additional 754 shares during the quarter. Revolve […]
Pacific Sage Partners LLC reduced its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 15.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,230 shares of the biopharmaceutical company’s stock after selling 575 shares during the quarter. Pacific Sage […]